1
A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:September 16, 2012Completed
SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Olopatadine Hydrochloride as an Intervention: 57 Clinical Trials
Hide Studies Not Open or Pending
2
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
Condition(s):Allergic ConjunctivitisLast Updated:October 17, 2017Completed
3
Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:October 1, 2018Withdrawn
4
An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:July 31, 2014Completed
5
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
Condition(s):Allergic ConjunctivitisLast Updated:July 30, 2014Completed
6
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
Condition(s):Perennial Allergic RhinitisLast Updated:January 12, 2018Completed
7
Comparing Patient Satisfaction With Pataday or Bepreve
Condition(s):Eye AllergiesLast Updated:January 8, 2014Completed
8
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
Condition(s):Rhinitis, Allergic, Seasonal; Conjunctivitis, AllergicLast Updated:January 24, 2012Completed
9
Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
Condition(s):Conjunctivitis, Allergic; Conjunctivitis, VernalLast Updated:September 17, 2019Recruiting
10
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
Condition(s):Allergic ConjunctivitisLast Updated:May 28, 2013Completed
11
Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
Condition(s):Seasonal Allergic ConjunctivitisLast Updated:February 17, 2012Completed
12
Safety and Comfort of AL-4943A Ophthalmic Solution
Condition(s):Allergic ConjunctivitisLast Updated:February 27, 2015Completed
13
Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
Condition(s):Allergic ConjunctivitisLast Updated:July 28, 2014Completed
14
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:August 10, 2017Completed
15
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Condition(s):Allergic ConjunctivitisLast Updated:May 11, 2015Completed
16
Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
Condition(s):Allergic ConjunctivitisLast Updated:October 5, 2015Completed
17
Olopatadine Eye Drops and Allergy Skin Testing
Condition(s):Allergic Rhinitis; Allergic ConjunctivitisLast Updated:June 12, 2017Completed
18
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
Condition(s):Seasonal Allergic ConjunctivitisLast Updated:April 11, 2012Completed
19
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
Condition(s):Seasonal Allergic RhinitisLast Updated:February 23, 2010Completed
20
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
Condition(s):Allergic RhinitisLast Updated:February 23, 2010Completed
21
Effect of Olopatadine on Allergic Tear Mediators
Condition(s):Allergic ConjunctivitisLast Updated:August 23, 2018Completed
22
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:March 5, 2012Completed
23
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:July 18, 2014Completed
24
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
Condition(s):Seasonal Allergic RhinitisLast Updated:March 23, 2010Completed
25
Patient Perception Study for AL-4943A
Condition(s):Allergic ConjunctivitisLast Updated:December 15, 2016Completed
26
Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:February 27, 2014Completed
27
Safety Study of Olopatadine Nasal Spray
Condition(s):Perennial Allergic RhinitisLast Updated:September 29, 2017Completed
28
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Condition(s):Seasonal Allergic Conjunctivitis to RagweedLast Updated:September 16, 2013Terminated
29
A Six-Week Safety Study of an Investigational Ophthalmic Solution
Condition(s):Allergic ConjunctivitisLast Updated:February 27, 2014Completed
30
Mast-Cell Stabilizing Effects of Olopatadine
Condition(s):Allergic ConjunctivitisLast Updated:November 18, 2016Completed
31
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Condition(s):Conjunctivitis, AllergicLast Updated:April 9, 2019Completed
32
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
Condition(s):Conjunctivitis, AllergicLast Updated:November 27, 2013Completed
33
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:May 15, 2009Completed
34
An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo
Condition(s):Allergic RhinitisLast Updated:February 21, 2012Withdrawn
35
Assessment of Alcon’s Ocular Image Quantification System
Condition(s):Allergic ConjunctivitisLast Updated:December 16, 2012Completed
36
Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
Condition(s):Seasonal Allergic RhinitisLast Updated:June 12, 2013Completed
37
Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition(s):Seasonal Allergic RhinitisLast Updated:June 18, 2018Completed
38
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Condition(s):Allergic RhinitisLast Updated:February 23, 2010Completed
39
Comparison of CL Wear Between Two Allergy Drops
Condition(s):Allergic ConjunctivitisLast Updated:October 5, 2010Withdrawn
40
Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
Condition(s):Allergic ConjunctivitisLast Updated:May 29, 2012Completed
41
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Condition(s):Vasomotor RhinitisLast Updated:April 14, 2011Completed
42
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:April 27, 2015Completed
43
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Condition(s):Conjunctivitis, AllergicLast Updated:April 2, 2008Completed
44
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Condition(s):Conjunctivitis, AllergicLast Updated:January 18, 2013Completed
45
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
Condition(s):Seasonal Allergic RhinitisLast Updated:April 22, 2010Completed
46
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition(s):Seasonal Allergic RhinitisLast Updated:August 28, 2018Completed
47
A Comparison of the Safety and Comfort of AC-170
Condition(s):Normal Ocular HealthLast Updated:September 13, 2017Completed
48
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:November 5, 2014Completed
49
To Study GSP 301 in Patients With Seasonal Allergic Rhinitis
Condition(s):Seasonal Allergic RhinitisLast Updated:May 26, 2017Completed
50
Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition(s):Seasonal Allergic Rhinitis (SAR)Last Updated:April 5, 2018Completed
51
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:February 28, 2018Completed
52
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Condition(s):Rhinitis, Allergic, SeasonalLast Updated:August 21, 2019Completed
53
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
Condition(s):Rhinitis, Allergic, Perennial; Rhinitis, Allergic, NonseasonalLast Updated:September 14, 2017Completed
54
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)
Condition(s):Rhinoconjunctivitis; Rhinitis; Conjunctivitis; AllergyLast Updated:January 18, 2017Completed
55
Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)
Condition(s):Rhinoconjunctivitis; Rhinitis; Conjunctivitis; AllergyLast Updated:January 18, 2017Completed
56
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
Condition(s):Seasonal Allergic Rhinitis (SAR)Last Updated:September 19, 2019Completed
57
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
Condition(s):Perennial Allergic RhinitisLast Updated:August 17, 2018Completed